Injectable Platelet-Rich Fibrin Added to MINST for Grade II Furcation Defects
Official title: Evaluation of Injectable Platelet-Rich Fibrin With Minimally Invasive Non-Surgical Technique in Treatment of Grade II Furcation Defects: A Randomized Clinical Trial
Run by October 6 University · NCT07787949 · Data updated 2026-11-12
Aiming to see if adding injectable platelet-rich fibrin to a minimally invasive non-surgical cleaning helps treat certain tooth defects better than MINST alone.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | October 6 University Academic / other |
| Locations | 1 site (Giza, Giza Governorate) |
| Status | Recruiting |
| Started | March 11, 2026 |
| Main results expected | March 11, 2027 |
| Study ends | March 11, 2027 |
| Registry record updated | August 26, 2026 |
| Trial ID | NCT07787949 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults over 18 with stage III, grade B periodontitis and a class II furcation defect, good oral hygiene, and commitment to follow-up.
✕Probably not a fit
Patients with systemic conditions affecting regeneration, smokers, recent periodontal surgery, or those who cannot follow up may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This trial compares MINST alone to MINST plus injectable platelet-rich fibrin (i-PRF) for managing class II furcation defects in adults with Stage III, Grade B periodontitis. It uses magnification during debridement to preserve tissue and enhance root decontamination, with the experimental arm receiving i-PRF to potentially boost regenerative outcomes. Outcomes will be assessed clinically and radiographically to determine whether the combination improves tissue stability and defect resolution. The study is conducted at October 6 University, with participants meeting specific inclusion criteria and agreeing to ongoing maintenance follow-up. The design focuses on real-world applicability of a minimally invasive approach augmented by a biologic agent.
Why it matters
Potential benefit: If successful, patients could experience greater defect resolution and improved periodontal stability with a less invasive treatment.
How similar studies have gone: Other studies have shown promise with MINST and regenerative adjuncts, but results vary and this specific combination is being tested in this setting.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients of both genders \>18 years old, medically free of systemic diseases affecting periodontal regeneration. * Diagnosis of stage III, grade B periodontitis (according to the AAP/EFP classification 2018) with the presence of class II furcation defect in either the maxillary (buccal) or mandibular arch (buccal or lingual) as determined by clinical evaluation and confirmed by radiographic evaluation. * Gingival margin and interdental bone positioned coronally to the furcation entrance. * Commitment to maintenance visits and follow-up. * Absence of primary endodontic lesions. Exclusion Criteria: * Patients suffering from any systemic diseases that may affect the outcome of periodontal therapy, including diabetes, immune deficiencies, etc; * Patients that received periodontal surgical treatments in the past 12 months. * Smoking (current or in past 5 years) * Prolonged treatment with antibiotics or anti-inflammatory agents within 6 months prior to periodontal therapy. * Pregnant and lactating females. * Teeth with hopeless prognosis * Third molars
Where it's running
-
October 6 University (Faculty of Dentistry)
Giza, Giza Governorate, Egypt Recruiting
Study contacts
- Study coordinator: Moustafa A Ahmed, B.D.S
- Email: 23110295.pg@o6u.edu.eg
- Phone: 00201098378998
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Injectable platelet-rich fibrin for faster orthodontic tooth movement
This study is testing if an injectable treatment made from platelets can help speed up tooth movement for people getting braces.
-
Bone substitutes with NIPSA for intrabony periodontal defects
This study tests two bone substitutes (GTO and GenOs) used with the NIPSA technique to see which supports better gum and bone healing in adults with Stage III periodontitis.
-
Renal perfusion during minimally invasive abdominal surgery using ultrasound and NIRS
Researchers will test if Doppler ultrasound RRI and NIRS-based rSO₂ can detect changes in kidney perfusion during elective laparoscopic surgery in adults with varying health status.
-
Comparing postoperative pain after robotic versus laparoscopic colorectal surgery
We will test whether robotic surgery causes less pain than laparoscopic surgery for adults having elective colon (right or left hemicolectomy) operations who meet the hospital's enhanced recovery (RICA) protocol.
-
Comparing two surgical approaches for lymphadenectomy in endometrial cancer
This study is testing two different surgical methods for removing lymph nodes in women with early-stage endometrial cancer to see which one works better.
-
Evaluating pain management methods for minimally invasive cancer surgery
This study is testing which pain management method works best for people undergoing minimally invasive cancer surgery by comparing three different approaches.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.